(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VKORC1 mRNA] CTD PMID:31150632 1,2-dimethylhydrazine decreases expression ISO RGD:1332416 6480464 1, 2-Dimethylhydrazine results in decreased expression of VKORC1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1332416 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VKORC1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:1332416 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VKORC1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of VKORC1 mRNA CTD PMID:17557909 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1332416 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1332416 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VKORC1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of VKORC1 mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of VKORC1 mRNA CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of VKORC1 mRNA CTD PMID:22298810 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of VKORC1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of VKORC1 mRNA CTD PMID:21346803 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of VKORC1 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1604306 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VKORC1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VKORC1 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1332416 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of VKORC1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1604306 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of VKORC1 protein CTD PMID:34186270 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of VKORC1 mRNA CTD PMID:36041667 4-hydroxycoumarin decreases activity ISO RGD:1604306 6480464 4-hydroxycoumarin results in decreased activity of VKORC1 protein CTD PMID:29581108 4-hydroxycoumarin multiple interactions ISO RGD:1604306 6480464 4-hydroxycoumarin inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1] CTD PMID:29581108 7-Hydroxywarfarin affects abundance ISO RGD:1604306 6480464 VKORC1 gene polymorphism affects the abundance of 7-hydroxywarfarin CTD PMID:25986145 acenocoumarol affects response to substance ISO RGD:1604306 6480464 VKORC1 gene polymorphism affects the susceptibility to Acenocoumarol more ... CTD PMID:16201835 more ... acenocoumarol decreases activity ISO RGD:1604306 6480464 Acenocoumarol results in decreased activity of VKORC1 protein CTD PMID:29581108 acenocoumarol multiple interactions ISO RGD:1604306 6480464 Acenocoumarol inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1] CTD PMID:29581108 acenocoumarol increases response to substance ISO RGD:1604306 6480464 VKORC1 protein results in increased susceptibility to Acenocoumarol CTD PMID:16869821 acenocoumarol decreases response to substance ISO RGD:1604306 6480464 VKORC1 promoter polymorphism results in decreased susceptibility to Acenocoumarol, VKORC1 protein polymorphism results in decreased susceptibility to Acenocoumarol CTD PMID:17036862 , PMID:19875892 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of VKORC1 mRNA CTD PMID:31881176 acetylsalicylic acid increases response to substance ISO RGD:1604306 6480464 VKORC1 gene SNP results in increased susceptibility to Aspirin CTD PMID:28338108 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of VKORC1 mRNA CTD PMID:28959563 benzo[a]pyrene multiple interactions ISO RGD:1332416 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to VKORC1 promoter] CTD PMID:19654925 benzo[a]pyrene increases methylation ISO RGD:1604306 6480464 Benzo(a)pyrene results in increased methylation of VKORC1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1332416 6480464 Benzo(a)pyrene results in decreased expression of VKORC1 mRNA CTD PMID:27195522 benzo[a]pyrene decreases expression ISO RGD:1604306 6480464 Benzo(a)pyrene results in decreased expression of VKORC1 mRNA CTD PMID:20106945 , PMID:32234424 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of VKORC1 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of VKORC1 mRNA CTD PMID:36041667 bisphenol A decreases expression ISO RGD:1332416 6480464 bisphenol A results in decreased expression of VKORC1 mRNA CTD PMID:33221593 bisphenol A affects expression ISO RGD:1604306 6480464 bisphenol A affects the expression of VKORC1 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1604306 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VKORC1 mRNA CTD PMID:28628672 Bisphenol B increases expression ISO RGD:1604306 6480464 bisphenol B results in increased expression of VKORC1 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:1604306 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VKORC1 mRNA CTD PMID:28628672 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of VKORC1 mRNA CTD PMID:36041667 Brodifacoum decreases activity ISO RGD:1604306 6480464 bromfenacoum results in decreased activity of VKORC1 protein CTD PMID:29581108 Brodifacoum multiple interactions ISO RGD:1604306 6480464 bromfenacoum inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1] CTD PMID:29581108 Bromadiolone affects response to substance EXP 6480464 VKORC1 protein affects the susceptibility to bromadiolone CTD PMID:17994578 Bromadiolone multiple interactions ISO RGD:1604306 6480464 bromadiolone inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1] CTD PMID:29581108 Bromadiolone decreases activity ISO RGD:1604306 6480464 bromadiolone results in decreased activity of VKORC1 protein CTD PMID:29581108 Bromadiolone decreases response to substance ISO RGD:1332416 6480464 VKORC1 protein polymorphism results in decreased susceptibility to bromadiolone CTD PMID:27117082 Bromadiolone decreases response to substance EXP 6480464 VKORC1 gene mutant form results in decreased susceptibility to bromadiolone more ... CTD PMID:17994578 more ... C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of VKORC1 mRNA CTD PMID:19167457 carbon nanotube decreases expression ISO RGD:1332416 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 Chlorophacinone decreases response to substance EXP 6480464 VKORC1 gene mutant form results in decreased susceptibility to chlorophacinone CTD PMID:19752778 chloropicrin increases expression ISO RGD:1604306 6480464 chloropicrin results in increased expression of VKORC1 mRNA CTD PMID:26352163 choline multiple interactions ISO RGD:1332416 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VKORC1 gene CTD PMID:20938992 cisplatin increases expression ISO RGD:1332416 6480464 Cisplatin results in increased expression of VKORC1 mRNA CTD PMID:25270620 clobetasol increases expression ISO RGD:1332416 6480464 Clobetasol results in increased expression of VKORC1 mRNA CTD PMID:27462272 clofibrate decreases expression ISO RGD:1332416 6480464 Clofibrate results in decreased expression of VKORC1 mRNA CTD PMID:17585979 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of VKORC1 mRNA CTD PMID:17602206 copper atom decreases expression EXP 6480464 Copper results in decreased expression of VKORC1 mRNA CTD PMID:22465980 , PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of VKORC1 mRNA CTD PMID:22465980 , PMID:30556269 copper(II) sulfate decreases expression ISO RGD:1604306 6480464 Copper Sulfate results in decreased expression of VKORC1 mRNA CTD PMID:19549813 Coumachlor decreases activity ISO RGD:1604306 6480464 coumachlor results in decreased activity of VKORC1 protein CTD PMID:29581108 Coumachlor multiple interactions ISO RGD:1604306 6480464 coumachlor inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1], coumachlor inhibits the reaction [VKORC1 protein results in increased reduction of vitamin K1 oxide] CTD PMID:29581108 coumarin decreases response to substance ISO RGD:1604306 6480464 VKORC1 gene mutant form results in decreased susceptibility to coumarin CTD PMID:18278162 coumarin increases response to substance ISO RGD:1604306 6480464 VKORC1 gene mutant form results in increased susceptibility to coumarin, VKORC1 promoter SNP results in increased susceptibility to coumarin CTD PMID:17849045 , PMID:18278162 coumarins affects activity ISO RGD:1604306 6480464 Coumarins affects the activity of VKORC1 protein CTD PMID:18278162 Coumatetralyl decreases response to substance EXP 6480464 VKORC1 protein polymorphism results in decreased susceptibility to coumatetralyl CTD PMID:27117082 Coumatetralyl multiple interactions ISO RGD:1604306 6480464 coumatetralyl inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1] CTD PMID:29581108 Coumatetralyl decreases activity ISO RGD:1604306 6480464 coumatetralyl results in decreased activity of VKORC1 protein CTD PMID:29581108 Coumatetralyl decreases response to substance ISO RGD:1332416 6480464 VKORC1 protein polymorphism results in decreased susceptibility to coumatetralyl CTD PMID:27117082 coumestrol multiple interactions ISO RGD:1604306 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:1604306 6480464 Cyclosporine results in decreased expression of VKORC1 mRNA CTD PMID:20106945 dehydroacetic acid decreases activity EXP 6480464 dehydroacetic acid results in decreased activity of VKORC1 protein CTD PMID:17941040 dexamethasone multiple interactions ISO RGD:1604306 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VKORC1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VKORC1 mRNA CTD PMID:28628672 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of VKORC1 mRNA CTD PMID:17379624 , PMID:21266533 dicoumarol multiple interactions ISO RGD:1604306 6480464 Dicumarol inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1] CTD PMID:29581108 dicoumarol decreases activity ISO RGD:1604306 6480464 Dicumarol results in decreased activity of VKORC1 protein CTD PMID:29581108 Difenacoum decreases response to substance ISO RGD:1332416 6480464 VKORC1 protein polymorphism results in decreased susceptibility to difenacoum CTD PMID:27117082 Difenacoum decreases response to substance EXP 6480464 VKORC1 protein mutant form results in decreased susceptibility to difenacoum, VKORC1 protein polymorphism results in decreased susceptibility to difenacoum CTD PMID:27117082 , PMID:29155484 Difethialone decreases activity EXP 6480464 difethialone results in decreased activity of VKORC1 protein CTD PMID:32047980 dioxygen multiple interactions ISO RGD:1332416 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of VKORC1 mRNA CTD PMID:30529165 disodium selenite decreases expression ISO RGD:1604306 6480464 Sodium Selenite results in decreased expression of VKORC1 mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO RGD:1604306 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VKORC1 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1604306 6480464 Doxorubicin results in decreased expression of VKORC1 mRNA CTD PMID:29803840 elemental selenium multiple interactions ISO RGD:1604306 6480464 [Selenium co-treated with Vitamin E] results in increased expression of VKORC1 mRNA CTD PMID:19244175 elemental selenium increases expression ISO RGD:1604306 6480464 Selenium results in increased expression of VKORC1 mRNA CTD PMID:19244175 Enterolactone multiple interactions ISO RGD:1604306 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VKORC1 mRNA CTD PMID:19167446 etoposide increases expression ISO RGD:1332416 6480464 Etoposide results in increased expression of VKORC1 mRNA CTD PMID:25270620 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of VKORC1 mRNA CTD PMID:23962444 fluindione decreases activity ISO RGD:1604306 6480464 fluindione results in decreased activity of VKORC1 protein CTD PMID:29581108 fluindione multiple interactions ISO RGD:1604306 6480464 fluindione inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1], fluindione inhibits the reaction [VKORC1 protein results in increased reduction of vitamin K1 oxide] CTD PMID:29581108 folic acid multiple interactions ISO RGD:1332416 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 GW 4064 multiple interactions ISO RGD:1332416 6480464 GW 4064 promotes the reaction [NR1H4 protein binds to VKORC1 gene] CTD PMID:20091679 indometacin multiple interactions ISO RGD:1604306 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VKORC1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of VKORC1 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:1604306 6480464 Ivermectin results in decreased expression of VKORC1 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1332416 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VKORC1 gene CTD PMID:20938992 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of VKORC1 mRNA CTD PMID:17602206 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of VKORC1 mRNA CTD PMID:24136188 paracetamol affects expression ISO RGD:1332416 6480464 Acetaminophen affects the expression of VKORC1 mRNA CTD PMID:17562736 phenindione multiple interactions ISO RGD:1604306 6480464 Phenindione inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1] CTD PMID:29581108 phenindione decreases activity ISO RGD:1604306 6480464 Phenindione results in decreased activity of VKORC1 protein CTD PMID:29581108 phenprocoumon affects response to substance ISO RGD:1604306 6480464 VKORC1 gene polymorphism affects the susceptibility to Phenprocoumon, VKORC1 intron SNP affects the susceptibility to Phenprocoumon CTD PMID:15536456 more ... phenprocoumon decreases activity ISO RGD:1604306 6480464 Phenprocoumon results in decreased activity of VKORC1 protein CTD PMID:29581108 phenprocoumon multiple interactions ISO RGD:1604306 6480464 Phenprocoumon inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1] CTD PMID:29581108 phenprocoumon decreases response to substance ISO RGD:1604306 6480464 VKORC1 protein polymorphism results in decreased susceptibility to Phenprocoumon CTD PMID:17036862 phylloquinone increases reduction ISO RGD:1604306 6480464 VKORC1 protein results in increased reduction of Vitamin K 1 CTD PMID:29581108 phylloquinone multiple interactions ISO RGD:1604306 6480464 4-hydroxycoumarin inhibits the reaction [VKORC1 protein results in increased reduction of Vitamin K 1] more ... CTD PMID:29581108 pyrimidifen increases expression ISO RGD:1604306 6480464 pyrimidifen results in increased expression of VKORC1 mRNA CTD PMID:33512557 resveratrol multiple interactions ISO RGD:1604306 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of VKORC1 mRNA CTD PMID:19167446 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of VKORC1 mRNA CTD PMID:28374803 rotenone increases expression ISO RGD:1604306 6480464 Rotenone results in increased expression of VKORC1 mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:1604306 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VKORC1 mRNA CTD PMID:27188386 selenium atom multiple interactions ISO RGD:1604306 6480464 [Selenium co-treated with Vitamin E] results in increased expression of VKORC1 mRNA CTD PMID:19244175 selenium atom increases expression ISO RGD:1604306 6480464 Selenium results in increased expression of VKORC1 mRNA CTD PMID:19244175 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of VKORC1 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:1332416 6480464 Carbon Tetrachloride results in decreased expression of VKORC1 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VKORC1 mRNA] CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of VKORC1 mRNA CTD PMID:23411599 , PMID:34492290 valproic acid increases expression ISO RGD:1332416 6480464 Valproic Acid results in increased expression of VKORC1 mRNA CTD PMID:21427059 valproic acid increases expression ISO RGD:1604306 6480464 Valproic Acid results in increased expression of VKORC1 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1604306 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VKORC1 mRNA CTD PMID:27188386 valproic acid affects expression ISO RGD:1604306 6480464 Valproic Acid affects the expression of VKORC1 mRNA CTD PMID:25979313 vitamin E multiple interactions ISO RGD:1604306 6480464 [Selenium co-treated with Vitamin E] results in increased expression of VKORC1 mRNA CTD PMID:19244175 vitamin E increases expression ISO RGD:1604306 6480464 Vitamin E results in increased expression of VKORC1 mRNA CTD PMID:19244175 vitamin K epoxide multiple interactions ISO RGD:1604306 6480464 [VKORC1 protein results in increased reduction of vitamin K1 oxide] which results in increased carboxylation of and results in increased activity of F9 protein more ... CTD PMID:23928358 , PMID:29581108 vitamin K epoxide multiple interactions EXP 6480464 Warfarin inhibits the reaction [VKORC1 protein affects the reduction of vitamin K1 oxide] CTD PMID:23928358 vitamin K epoxide affects reduction EXP 6480464 VKORC1 protein affects the reduction of vitamin K1 oxide CTD PMID:23928358 vitamin K epoxide increases reduction ISO RGD:1604306 6480464 VKORC1 protein results in increased reduction of vitamin K1 oxide CTD PMID:23928358 , PMID:29581108 warfarin affects response to substance ISO RGD:1604306 6480464 VKORC1 3' UTR SNP affects the susceptibility to Warfarin more ... CTD PMID:15358623 more ... warfarin decreases activity EXP 6480464 Warfarin results in decreased activity of VKORC1 protein CTD PMID:17941040 warfarin decreases response to substance EXP 6480464 VKORC1 gene mutant form results in decreased susceptibility to Warfarin, VKORC1 protein polymorphism results in decreased susceptibility to Warfarin CTD PMID:14765194 more ... warfarin affects response to substance EXP 6480464 VKORC1 protein mutant form affects the susceptibility to Warfarin CTD PMID:23018795 warfarin decreases activity ISO RGD:1604306 6480464 Warfarin results in decreased activity of VKORC1 protein CTD PMID:14765194 more ... warfarin decreases response to substance ISO RGD:1332416 6480464 VKORC1 gene mutant form results in decreased susceptibility to Warfarin, VKORC1 protein polymorphism results in decreased susceptibility to Warfarin CTD PMID:19200363 , PMID:27117082 warfarin decreases metabolic processing ISO RGD:1604306 6480464 VKORC1 gene polymorphism results in decreased metabolism of Warfarin CTD PMID:20073138 warfarin multiple interactions EXP 6480464 Warfarin inhibits the reaction [VKORC1 protein affects the reduction of vitamin K1 oxide] CTD PMID:23928358 warfarin affects metabolic processing ISO RGD:1604306 6480464 VKORC1 protein affects the metabolism of Warfarin CTD PMID:20073138 warfarin increases response to substance ISO RGD:1604306 6480464 VKORC1 intron polymorphism results in increased susceptibility to Warfarin more ... CTD PMID:16676068 more ... warfarin multiple interactions ISO RGD:1604306 6480464 [CYP4F2 gene polymorphism co-treated with VKORC1 gene mutant form] affects the susceptibility to Warfarin more ... CTD PMID:21084764 more ... warfarin affects abundance ISO RGD:1604306 6480464 VKORC1 gene polymorphism affects the abundance of Warfarin CTD PMID:25986145 warfarin decreases response to substance ISO RGD:1604306 6480464 VKORC1 3' UTR results in decreased susceptibility to Warfarin more ... CTD PMID:14765194 more ...